Clinical trial
Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study
NCT00637637 is registered in ClinicalTrials.gov with Oncology Institute of Southern Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study
- Lead sponsor
- Oncology Institute of Southern Switzerland
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2007
- Completion date
- Not reported
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cancer